company background image
FAGRB logo

Fagron BATS-CHIXE:FAGRB Stock Report

Last Price

€16.66

Market Cap

€1.3b

7D

0%

1Y

10.5%

Updated

05 Mar, 2024

Data

Company Financials +

FAGRB Stock Overview

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide.

FAGRB fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance3/6
Financial Health4/6
Dividends2/6

Fagron NV Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fagron
Historical stock prices
Current Share Price€16.66
52 Week High€17.43
52 Week Low€14.72
Beta0.29
1 Month Change0%
3 Month Changen/a
1 Year Change10.48%
3 Year Change-12.20%
5 Year Change1.55%
Change since IPO-52.82%

Recent News & Updates

Recent updates

Shareholder Returns

FAGRBGB HealthcareGB Market
7D0%-1.9%2.1%
1Y10.5%-22.2%3.8%

Return vs Industry: FAGRB exceeded the UK Healthcare industry which returned -13.3% over the past year.

Return vs Market: FAGRB exceeded the UK Market which returned -5.4% over the past year.

Price Volatility

Is FAGRB's price volatile compared to industry and market?
FAGRB volatility
FAGRB Average Weekly Movementn/a
Healthcare Industry Average Movement7.6%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.5%

Stable Share Price: FAGRB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine FAGRB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19903,035Rafael Padillahttps://www.fagron.com

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.

Fagron NV Fundamentals Summary

How do Fagron's earnings and revenue compare to its market cap?
FAGRB fundamental statistics
Market cap€1.30b
Earnings (TTM)€70.55m
Revenue (TTM)€762.99m

18.5x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FAGRB income statement (TTM)
Revenue€762.99m
Cost of Revenue€430.38m
Gross Profit€332.61m
Other Expenses€262.07m
Earnings€70.55m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 01, 2024

Earnings per share (EPS)0.97
Gross Margin43.59%
Net Profit Margin9.25%
Debt/Equity Ratio69.6%

How did FAGRB perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.